Clients News • MC Services corporate website
5522
paged,page-template-default,page,page-id-5522,paged-70,page-paged-70,bridge-core-2.1.4,qode-listing-1.0.1,qode-social-login-1.0,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode-title-hidden,paspartu_enabled,qode_grid_1400,footer_responsive_adv,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-20.1,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,bridge-child,wpb-js-composer js-comp-ver-6.5.0,vc_responsive

CLIENT NEWS

 

 

  • Apogenix Announces Oral and Poster Presentations at Upcoming International Conferences
    www.apogenix.com
  • Interim Results for the six months ended 31 December 2018
    www.allergytherapeutics.com
  • Newron announces 2018 financial results and provides outlook for 2019
    www.newron.com
  • Abivax Chosen to Deliver ABX464 Oral Presentation at Digestive Disease Week (DDW) Conference in the U.S.
    www.abivax.com
  • NOXXON to launch NOX-A12 with radiotherapy clinical trial in patients with brain cancer
    www.noxxon.com
  • Bencard Allergie GmbH: Specialist in allergen-specific immunotherapies addresses new practical recommendations for the treatment of insect venom allergy with introduction of user-friendly pack size for insect venom product
    www.medigene.com
  • Biom’up sees a strong commercial uptake in HEMOBLAST(TM) Bellows in the US and Europe
    www.biomup.com
  • Avisa Reports on Progress with Biomarker AV BreathTest™ Platform
    www.avisapharma.com
  • HPS Home Power Solutions GmbH to present all-in-one energy storage system Picea at ees Europe 2018
    www.homepowersolutions.de
  • NOXXON presents top-line data from nox-a12 monotherapy part of ongoing metastatic colorectal and pancreatic cancer trial
    www.noxxon.com